Editorial - Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2
BERKELEY, CA (UroToday.com) - In the online version of Cancer Research, a group of Harvard investigators report that the epidermal growth factor (EGF) receptor (EGFR) and tyrosine kinase ErbB2 can negatively regulate the androgen receptor (AR) in prostate cancer models.
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
